#2-85E. The Critical Window: Early Damage Accrual and Predictors in Sjögren’s Disease (Rheumatology, 2025)

Is Sjögren’s disease truly a slowly progressing condition for all patients, or are we missing a crucial window for intervention? This episode explores a significant 15-year multicentre study that challenges the "indolent" reputation of this disease. By tracking 102 patients, the researchers revealed that the most substantial burden of irreversible organ damage—measured by the SSDDI score—accumulates within the first five years after diagnosis rather than linearly over time. Crucially, the study identifies that baseline lymphadenopathy and high disease activity (ESSDAI) are potent independent predictors of this long-term deterioration. While these results provide a compelling argument for early stratification, listeners must critically weigh these findings against the study's limitations, specifically its retrospective design and relatively small sample size which may affect generalizability. For clinicians, this evidence suggests that the initial years following diagnosis are not a time for "watchful waiting," but a critical period where identifying high-risk features like lymphadenopathy could allow for interventions that prevent permanent structural damage.

Citation: Cafaro G, Dei B, Dal Pozzolo R, et al. Phenotypic clusters of long-term damage in Sjögren’s disease: a 15-year multicentre study. Rheumatology (Oxford). 2025. DOI: 10.1093/rheumatology/keaf434

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.